MEDICAL ALLEY, MN – Carbon Medical Technologies, Inc., a St. Paul-based company that designs and manufactures medical devices using a proprietary pyrolytic carbon coating technology, has entered into a partnership with Innovation Oncology Solutions, Inc. to distribute the BiomarC Fiducial Marker product family including: BiomarC, BiomarC Enh, BiomarC PRO, BiomarC EX, and BiomarC Secure.
“We at Innovation Oncology Solutions are extremely pleased to become a U.S. distribution partner for Carbon Medical Technologies’ BiomarC fiducial product line in the U.S.,” said David Holdford, Director of Sales at Innovative Oncology Solutions, Inc. “Their authentically novel idea to encase different core materials in a pyrolytic carbon coating strikes a beautiful balance between lowering image artifact and beam shadowing while also enhancing visibility on all pertinent imaging modalities. The gold standard is no longer gold!”
Through this partnership, Carbon Medical Technologies is able to expand its product distribution network across the United States to deliver its best-in-class fiducial products. “We at Carbon Medical Technologies are excited to partner with the talented team at Innovation Oncology Solutions,” said Stephanie Kent, President and Chief Executive Officer at Carbon Medical Technologies. “This partnership will quickly and efficiently expand access to the BiomarC product line of fiducial markers to meet the specific needs of U.S. customers seeking to enhance accuracy and efficiency during radiation therapy treatment.”
About Carbon Medical Technologies, Inc.
Carbon Medical Technologies, Inc. (CMT) is a privately held company formed in 1994 to design, develop, and manufacture permanent human implantable products utilizing pyrolytic carbon. Carbon is a naturally occurring element in the human body. As a result, pyrolytic carbon is not recognized by the human body as foreign, thus rendering it ideal as a permanent implant material. CMT operates a fully functional pyrolytic carbon coating facility, one of five known to exist in the world.
CMT has developed multiple FDA approved and CE Marked products and utilizes major medical device companies to market its products throughout the world. Currently, the pyrolytic carbon coating technology is incorporated into BiomarC implantable tissue markers developed for biopsy site marking and the BiomarC fiducial marker product line for radiation therapy treatment planning. CMT products also include a pyrolytic carbon based injectable bulking agent called Durasphere, which is used for the treatment of stress urinary incontinence in women, and additional indications outside of the US.
CMT also provides product development, contract manufacturing, and regulatory consulting for medical device companies. CMT is a medical device manufacturer with ISO 13485 certified and cGMP compliant quality systems. CMT maintains three different sterilization method validations and does final product assembly and packaging in an ISO Class 7 clean room environment.
About Innovative Oncology Solutions, Inc.
Innovative Oncology Solutions, Inc. (IOS) is a privately held company that was founded in 2016 by a group of medical sales, quality, and supply chain executives with numerous years of experience in the fields of oncology and medical device. IOS’ mission is to provide high-quality, reasonably priced products that solve unique clinical problems and improve the lives of patients and clinicians.
